IP Library Granted Patent US 10,905,492
Granted Patent B2
US 10,905,492 · App. 15/685,355 · Granted Feb 2, 2021

Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode

Inventor: Robert E. Neal, II (Blacksburg, VA)
Assignee: AngioDynamics, Inc.
A61B18/12A61B18/1477A61N1/0412A61B2018/00452A61B2018/00577A61B2018/00613A61B2018/00791A61B2018/00875A61B2018/00964A61B2018/143A61B2018/1432A61B2018/1475A61N1/327
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,905,492
App. No.
15/685,355
Granted
Feb 2, 2021
Kind
B2
Abstract

Techniques for High-Frequency Irreversible Electroporation (HFIRE) using a single-pole tine-style internal device communicating with an external surface electrode are described. In an embodiment, a system for ablating tissue cells in a treatment region of a patient's body by irreversible electroporation without thermally damaging the tissue cells is described. The system includes at least one single-pole electrode probe for insertion into the treatment region, the single-pole electrode probe including one or more tines. The system further includes at least one external surface electrode for placement outside the patient's body and configured to complete a circuit with the single-pole electrode probe. The system also includes a control device for controlling HFIRE pulses to the single-pole tine-style electrode and the skin-surface electrode for the delivery of electric energy to the treatment region. Other embodiments are described and claimed.

Claims (20)

1. A method for ablating tissue cells in a treatment region of a patient's body comprising: inserting a probe into the treatment region, the probe comprising one or more deployable tines and a tine electrode; placing a surface electrode on a first location on a surface of an organ of the patient, deploying the one or more deployable tines of the probe into the treatment region, applying a first set of electrical pulses between the tine electrode and the surface electrode in an amount sufficient to induce a first electrical pull zone and to induce irreversible electroporation of the treatment region, but insufficient to induce significant muscle contractions in the patient, wherein the first electrical pull zone increases a size of an initial substantially spherical ablation zone by up to 3 millimeters; moving the surface electrode to a second location on the surface of the organ of the patient; and applying a second set of electrical pulses between the tine electrode and the surface electrode in an amount sufficient to induce a second electrical pull zone.

2. The method of claim 1 , wherein the organ is skin.

3. The method of claim 1 , wherein the one or more deployable tines are arranged in multiple tiers around a shaft of the probe.

4. The method of claim 1 , wherein the step of applying the first set of electrical pulses comprises applying the electrical pulses having a pulse width of between 100 nanoseconds and 10 microseconds.

5. The method of claim 4 , wherein the first set of electrical pulses are delivered in burst widths of 500 nanoseconds to 1 millisecond.

6. The method of claim 5 , wherein a time delay between the burst widths is between 1 millisecond and 5 seconds.

7. The method of claim 1 , wherein the first set of electrical pulses are bi-phasic.

8. The method of claim 1 , wherein the step of applying the first set of electrical pulses is sufficient to induce non-thermal irreversible electroporation of the treatment region.

9. The method of claim 1 , further comprising the step of: moving the surface electrode to a third location on the surface of the organ; and applying a third set of electrical pulses between the tine electrode and the surface electrode in an amount sufficient to induce a third electrical pull zone.

10. The method of claim 1 , wherein the probe comprises an electrode probe.

11. The method of claim 1 , wherein the second electrical pull zone increases the size of the initial substantially spherical ablation zone by up to 3 millimeters.

12. The method of claim 1 , wherein delivery of a paralytic is not required prior to the step of applying the first set of electrical pulses.

13. A method for ablating tissue cells in a treatment region of a patient's body comprising: inserting an electrode probe into the treatment region, the electrode probe comprises one or more deployable tines and at least one tine electrode; placing a surface electrode at a first location on a surface of an organ of the patient, deploying the one or more deployable tines of the electrode probe into the treatment region, applying a first set of electrical pulses between the at least one tine electrode and the surface electrode in an amount sufficient to induce a first electrical pull zone resulting in irreversible electroporation of the treatment region, but insufficient to induce tissue cell destruction by thermal damage, wherein the first electrical pull zone enlarges a spherical primary ablation zone by up to 3 millimeters; moving the surface electrode to a second location on the surface of the organ of the patient; and applying a second set of electrical pulses between the at least one tine electrode and the surface electrode in an amount sufficient to induce a second electrical pull zone.

14. The method of claim 13 , further comprising the steps of: moving the surface electrode to a third location on the surface of the organ of the patient; applying a third set of electrical pulses between the at least one tine electrode and the surface electrode to induce a third electrical pull zone; moving the surface electrode to a fourth location on the surface of the organ of the patient; applying a fourth set of electrical pulses between the at least one tine electrode and the surface electrode to induce a fourth electrical pull zone.

15. The method of claim 14 , wherein the first pull zone, the second pull zone, the third pull zone, and the fourth pull zone combine to result in a final ablation zone up to 10% larger than the primary ablation zone.

16. The method of claim 15 , wherein the step of applying the first set of electrical pulses further comprises applying the first set of electrical pulses having a pulse width of between 100 nanoseconds and 10 microseconds, wherein the first set of electrical pulses are delivered in burst widths of 500 nanoseconds to 1 millisecond.

17. The method of claim 16 , wherein a time delay between the burst widths is between 1 millisecond and 5 seconds.

18. The method of claim 13 , wherein the first set of electrical pulses are bi-phasic.

19. The method of claim 13 , wherein the step of applying first set of electrical pulses includes applying the first set of electrical pulses in a pattern which has been predetermined to maintain a temperature of the treatment region below 70 degrees C., and further comprising the step of:

moving the first surface electrode.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Jun 8, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 063940/0362 →
SECURITY INTEREST Recorded Aug 31, 2022
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 061360/0668 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2022
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ANGIODYNAMICS, INC.
Reel/Frame 061363/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2022
From: NEAL, ROBERT E, II
To: ANGIODYNAMICS, INC.
Reel/Frame 060935/0526 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Jun 5, 2019
From: ANGIODYNAMICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 049371/0657 →
Cited By (2)
US 12,582,433 US 12,599,397